Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations
Andrea Marıno, Stefano Stracquadanio, Edoardo Campanella, et al.
Antibiotics (2022) Vol. 12, Iss. 1, pp. 49-49
Open Access | Times Cited: 22

Showing 22 citing articles:

Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
Katarina Novović, Branko Jovčić
Antibiotics (2023) Vol. 12, Iss. 3, pp. 516-516
Open Access | Times Cited: 74
Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment
Shane Whelan, Brigid Lucey, Karen Finn
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2169-2169
Open Access | Times Cited: 58
Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic
Maria Mazzitelli, Darío Gregori, Lolita Sasset, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 984-984
Open Access | Times Cited: 27
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments
F Giovagnorio, Andrea De Vito, Giordano Madeddu, et al.
Antibiotics (2023) Vol. 12, Iss. 11, pp. 1621-1621
Open Access | Times Cited: 26
Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations
Andrea Marıno, Egle Augello, Stefano Stracquadanio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6814-6814
Open Access | Times Cited: 9
Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review
Paul-Henri Wicky, Joséphine Poiraud, M.A. Alves, et al.
Antibiotics (2023) Vol. 12, Iss. 6, pp. 991-991
Open Access | Times Cited: 16
Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii
Siqin Zhang, Lingfang Di, Qi Yan, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
Cefiderocol Efficacy in a Real-Life Setting: Single-Centre Retrospective Study
Gabriele Palermo, Alice Annalisa Medaglia, Luca Pipitò, et al.
Antibiotics (2023) Vol. 12, Iss. 4, pp. 746-746
Open Access | Times Cited: 13
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a multicenter clinical experience
Alessandro Russo, Sara Palma Gullì, A D’Avino, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 1, pp. 107190-107190
Closed Access | Times Cited: 4
Ceftazidime-Avibactam Treatment for Klebsiella pneumoniae Bacteremia in Preterm Infants in NICU: A Clinical Experience
Andrea Marıno, Sarah Pulvirenti, Edoardo Campanella, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1169-1169
Open Access | Times Cited: 10
Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol
Gabriele Bianco, Matteo Boattini, Monica Cricca, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14132-14153
Open Access | Times Cited: 3
Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion
Andrea Marıno, Edoardo Campanella, Stefano Stracquadanio, et al.
Antibiotics (2023) Vol. 12, Iss. 10, pp. 1521-1521
Open Access | Times Cited: 8
Management of ventilator‑associated pneumonia due to Stenotrophomonas maltophilia infection: A case report and literature review
Edoardo Campanella, Andrea Marıno, Stefano Stracquadanio, et al.
World Academy of Sciences Journal (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 4
Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations?
Béatrice Grabein, Francis F. Arhin, George L. Daikos, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2423-2447
Open Access | Times Cited: 1
Laryngeal leishmaniasis in a HIV‑positive patient: A case report and review of the literature
Viviana Fisicaro, Edoardo Campanella, Andrea Marıno, et al.
World Academy of Sciences Journal (2023) Vol. 5, Iss. 4
Open Access | Times Cited: 2
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii infections in critically ill patients: Experience at a tertiary-care teaching hospital ICU
Leyla Ferliçolak, Neriman Defne Altıntaş, Fügen Yörük
Journal of Intensive Medicine (2024) Vol. 4, Iss. 2, pp. 181-186
Open Access
A contribute on the fosfomycin mechanism of resistance in MDR organisms
Stefano Stracquadanio, Stefania Stefani
International Journal of Antimicrobial Agents (2024), pp. 107364-107364
Closed Access
Editorial: Value of a multidisciplinary approach for modern diagnosis of infectious diseases
Andrea Marıno, Stefano Stracquadanio, Stefano Marletta
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Outer membrane permeability of mcr-positive bacteria reveals potent synergy of colistin and macromolecular antibiotics against colistin-resistant Acinetobacter baumannii
Meisong Li, Furong Ma, Hui Zhao, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Risk Factors for Development and Mortality of Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
Liubing Li, Dubo Chen, Pingjuan Liu, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 5699-5706
Open Access
Carbapenem-resistant Acinetobacter baumannii and Ventilator-associated Pneumonia; Epidemiology, Risk Factors, and Current Therapeutic Approaches
Malihe Kazemi Najafabadi, Rasool Soltani
Journal of Research in Pharmacy Practice (2024) Vol. 13, Iss. 2, pp. 33-40
Open Access
High prevalence of pyogenic spondylodiscitis cases in a third level university infectious diseases center: A case series and literature review
Manuela Ceccarelli, Barbara Bellocchi, Antonio Campanella, et al.
World Academy of Sciences Journal (2023) Vol. 5, Iss. 5
Open Access
Page 1

Scroll to top